We have previously reported that the somatotropin regulatory peptides, growth hormone-releasing hormone (GRF) and somatostatin (SS) increase feeding when applied centrally in low picomole-range doses. The similarity between the dose-response characteristics and photoperiod sensitivities of these two peptide’s feeding effects, together with indirect evidence suggesting that these peptides interact functionally within the hypothalamus, suggests that GRF and SS may induce feeding via a common neural mechanism. The present studies sought to investigate this possibility. In the first experiment combined intracerebroventricular (icv) injections of optimal doses of GRF and SS were found to be less potent than icv injections of GRF or SS alone, suggesting that the mechanisms mediating GRF-induced and SS-induced feeding are not totally independent. In further studies, icv injections of antiserum raised against SS blocked GRF-induced feeding. In contrast, icv injections of antiserum raised against GRF were ineffective in blocking SS-induced feeding. These results suggest that SS may act downstream to GRF in a putative neural feeding mechanism which utilizes both peptides. The possible anatomical basis for such a feeding mechanism involving GRF and SS is discussed.

Keywords:
Feeding, Growth hormone-releasing factor, Somatostatin
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.